In Vivo Cortical Excitability Modulation in Major Depressive Disorder

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorFundacao Champalimaud

About this trial

The pathophysiology of Major Depression Disorder (MDD) is unclear, with several theories for its neurobiological mechanisms. One possible explanation is the presence of altered neuroplasticity, which can be studied by Transcranial Magnetic Stimulation (TMS). Using TMS to study these mechanisms is performed by applying electromagnetic stimuli to the motor cortex, to obtain measures of temporary cortical excitability modulation. It is known that depressed patients with higher cortical modulation are more responsive to a TMS treatment course. However, it is unknown if there are differences in cortical modulation between depressed patients and healthy subjects. Our goal is to answer this question and contribute towards clarification of the neuroplasticity mechanisms underlying MDD. Accordingly, the investigators will access cortical excitability modulation measures in both depressed patients and healthy volunteers and compare their results. The investigators will also re-assess these measures after 6 weeks of antidepressant treatment. Finally, the investigators will study the association between cortical excitability measures and cognitive processes using an innovative cognitive task.

Eligibility criteria

Qualifiers

None

Disqualifiers

Moderate to severe suicide risk;

Known personal history of bipolar disorder or psychotic disorder;

Alcohol or other substance abuse and/or dependence;

Developmental disorder;

Trial design

Treatments tested in this trial

  • No intervention/expousure

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators